QT Prolongation in Critically Ill Patients With SARS-CoV-2 Infection.

Wasim S El NekidyKhalid AlmutiHazem ElRefaeiBassam AtallahLana M MohammadWael AlMahmeedMohamed BadrKhaled AbdallahFadi HamedJihad Mallat

Published in: Journal of cardiovascular pharmacology and therapeutics (2022)

The prevalence of clinically significant QTc prolongation in critically ill patients with SARS-CoV-2 infection was high and independent of drugs used. Larger prospective observational studies are warranted to elucidate independent risk factors associated with clinically significant QTc prolongation in this study population.

Keyphrases

drug induced
respiratory syndrome coronavirus
risk factors
sars cov